Understanding Value Stocks

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company’s future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labeled as a value stock.

Benzinga Insights has compiled a list of value stocks in the healthcare sector that may be worth watching:

1. Viveve Medical VIVE - P/E: 0.09
2. Onconova Therapeutics ONTX - P/E: 0.86
3. OpGen OPGN - P/E: 2.63
4. Genesis Healthcare GEN - P/E: 1.92
5. Jaguar Health JAGX - P/E: 0.02

Viveve Medical has reported Q2 earnings per share at -0.45, which has increased by 45.12% compared to Q1, which was -0.82. Viveve Medical does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Onconova Therapeutics saw a decrease in earnings per share from -0.03 in Q1 to -0.04 now. Onconova Therapeutics does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

OpGen’s earnings per share for Q2 sits at -0.49, whereas in Q1, they were at -0.43. OpGen does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

Genesis Healthcare has reported Q2 earnings per share at -0.2, which has decreased by 171.43% compared to Q1, which was 0.28. Genesis Healthcare does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

This quarter, Jaguar Health experienced an increase in earnings per share, which was -0.56 in Q1 and is now -0.44. Jaguar Health does not have a dividend yield, which investors should be aware of when considering holding onto such a stock.

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.